학술논문
Phase 1-2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine
Document Type
Article
Author
Albert, G.; Cho, I.; Robertson, A.; Reed, P.; Neal, S.; Plested, J.S.; Zhu, M.; Cloney-Clark, S.; Zhou, H.; Smith, G.; Patel, N.; Desai, C.; Callahan, K.; Lewis, M.; Price-Abbott, P.; Formica, N.; Shinde, V.; Fries, L.; Wilkinson, B.; Glenn, G.M.; Frieman, M.B.; Haupt, R.E.; Logue, J.; McGrath, M.; Weston, S.; Piedra, P.A.; Lickliter, J.D.; Griffin, P.; Keech, C.
Source
In: New England Journal of Medicine . (New England Journal of Medicine, 10 December 2020, 383(24):2320-2332)
Subject
Language
English
ISSN
15334406
00284793
00284793